These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 14719046

  • 1. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression.
    Wichers MC, Maes M.
    J Psychiatry Neurosci; 2004 Jan; 29(1):11-7. PubMed ID: 14719046
    [Abstract] [Full Text] [Related]

  • 2. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpé S, Maes M.
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [Abstract] [Full Text] [Related]

  • 3. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr 29; 35(3):702-21. PubMed ID: 21185346
    [Abstract] [Full Text] [Related]

  • 4. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.
    Nephrol Dial Transplant; 2009 Jun 29; 24(6):1901-8. PubMed ID: 19155537
    [Abstract] [Full Text] [Related]

  • 5. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.
    Müller N, Schwarz MJ.
    Mol Psychiatry; 2007 Nov 29; 12(11):988-1000. PubMed ID: 17457312
    [Abstract] [Full Text] [Related]

  • 6. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Grant R.
    FEBS J; 2011 Nov 29; 278(22):4425-34. PubMed ID: 22032336
    [Abstract] [Full Text] [Related]

  • 7. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
    Myint AM, Kim YK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():304-13. PubMed ID: 24184687
    [Abstract] [Full Text] [Related]

  • 8. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
    Guillemin GJ, Smythe G, Takikawa O, Brew BJ.
    Glia; 2005 Jan 01; 49(1):15-23. PubMed ID: 15390107
    [Abstract] [Full Text] [Related]

  • 9. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
    Sanni LA, Thomas SR, Tattam BN, Moore DE, Chaudhri G, Stocker R, Hunt NH.
    Am J Pathol; 1998 Feb 01; 152(2):611-9. PubMed ID: 9466588
    [Abstract] [Full Text] [Related]

  • 10. Neurotoxic and neuroprotective metabolites of kynurenine in patients with renal cell carcinoma treated with interferon-alpha: course and relationship with psychiatric status.
    Van Gool AR, Verkerk R, Fekkes D, Bannink M, Sleijfer S, Kruit WH, van der Holt B, Scharpé S, Eggermont AM, Stoter G, Hengeveld MW.
    Psychiatry Clin Neurosci; 2008 Oct 01; 62(5):597-602. PubMed ID: 18950381
    [Abstract] [Full Text] [Related]

  • 11. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M, Mihaylova I, Ruyter MD, Kubera M, Bosmans E.
    Neuro Endocrinol Lett; 2007 Dec 01; 28(6):826-31. PubMed ID: 18063923
    [Abstract] [Full Text] [Related]

  • 12. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH.
    Brain; 1993 Dec 01; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [Abstract] [Full Text] [Related]

  • 13. Localisation of indoleamine 2,3-dioxygenase and kynurenine hydroxylase in the human placenta and decidua: implications for role of the kynurenine pathway in pregnancy.
    Ligam P, Manuelpillai U, Wallace EM, Walker D.
    Placenta; 2005 Jul 01; 26(6):498-504. PubMed ID: 15950064
    [Abstract] [Full Text] [Related]

  • 14. Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease.
    Swardfager W, Herrmann N, Dowlati Y, Oh PI, Kiss A, Walker SE, Lanctôt KL.
    Psychoneuroendocrinology; 2009 Nov 01; 34(10):1560-6. PubMed ID: 19540675
    [Abstract] [Full Text] [Related]

  • 15. Brain virus burden and indoleamine-2,3-dioxygenase expression during lentiviral infection of rhesus monkey are concomitantly lowered by 6-chloro-2',3'-dideoxyguanosine.
    Depboylu C, Reinhart TA, Takikawa O, Imai Y, Maeda H, Mitsuya H, Rausch D, Eiden LE, Weihe E.
    Eur J Neurosci; 2004 Jun 01; 19(11):2997-3005. PubMed ID: 15182307
    [Abstract] [Full Text] [Related]

  • 16. Neuronal localization of indoleamine 2,3-dioxygenase in mice.
    Roy EJ, Takikawa O, Kranz DM, Brown AR, Thomas DL.
    Neurosci Lett; 2005 Oct 21; 387(2):95-9. PubMed ID: 16076525
    [Abstract] [Full Text] [Related]

  • 17. Combined inhibition of indoleamine 2,3-dioxygenase and nitric oxide synthase modulates neurotoxin release by interferon-gamma-activated macrophages.
    Chiarugi A, Dello Sbarba P, Paccagnini A, Donnini S, Filippi S, Moroni F.
    J Leukoc Biol; 2000 Aug 21; 68(2):260-6. PubMed ID: 10947071
    [Abstract] [Full Text] [Related]

  • 18. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A, Quarantini LC, Sampaio AS, Lyra AC, Parise CL, Paraná R, de Oliveira IR, Koenen KC, Miranda-Scippa A, Guindalini C.
    Brain Behav Immun; 2011 Oct 21; 25(7):1491-7. PubMed ID: 21693183
    [Abstract] [Full Text] [Related]

  • 19. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ, Yuasa HJ, Austin CJ, Weiser S, Hunt NH.
    Int J Biochem Cell Biol; 2009 Mar 21; 41(3):467-71. PubMed ID: 18282734
    [Abstract] [Full Text] [Related]

  • 20. [Neuropsychiatric symptoms related to interferon alpha].
    Małyszczak K, Inglot M, Pawłowski T, Czarnecki M, Rymer W, Kiejna A.
    Psychiatr Pol; 2006 Mar 21; 40(4):787-97. PubMed ID: 17068950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.